Zhou Boda, Li Jizhao, Chen Shaomin, Zhou Enchen, Zheng Lemin, Zu Lingyun, Gao Wei
Department of Cardiovascular Medicine, Peking University Third Hospital, Beijing 100191, P.R. China.
Institute of Cardiovascular Sciences and Institute of Systems Biomedicine, School of Basic Medical Sciences and Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health, Peking University Health Science Center, Beijing 100191, P.R. China.
Exp Ther Med. 2016 Apr;11(4):1481-1486. doi: 10.3892/etm.2016.3060. Epub 2016 Feb 9.
The present study aimed to investigate the time course of changes in microparticles (MPs) in patients with ST-segment elevation myocardial infarction (STEMI) that underwent percutaneous transluminal coronary intervention (PCI). A total of 24 STEMI patients undergoing primary PCI were enrolled, and circulating MPs were detected immediately prior to and after PCI, and at 4, 24 and 48 h post-PCI. Standard Megamix beads, based measurement protocols, were employed to measure MPs of different cell origin, including endothelial MPs (EMPs), platelet MPs (PMPs) and leukocyte-derived MPs (LMPs), which were identified by CD144, CD41 and CD45, respectively. The results indicated that PMP levels were evidently elevated immediately after PCI, and reached a maximum level at 48 h. In addition, LMP and EMP levels were significantly decreased immediately after the PCI, and then increased gradually with time. The total quantity of the three aforementioned MP types increased gradually at 48 h following PCI. Furthermore, coronary angiographic Gensini scores were significantly positively correlated with the level of PMPs (r2=0.42; P=0.0006). Log-normalized high sensitivity-C-reactive-protein was also significantly correlated with LMPs (r2=0.86; P<0.01). In conclusion, the time course of the changes in circulating MPs of different cell origin, provided information on possible functions of different MPs in STEMI.
本研究旨在调查接受经皮冠状动脉腔内血管成形术(PCI)的ST段抬高型心肌梗死(STEMI)患者体内微粒(MPs)的变化时间进程。共纳入24例接受直接PCI的STEMI患者,在PCI术前、术后即刻以及术后4、24和48小时检测循环MPs。采用基于标准Megamix微珠的测量方案来测量不同细胞来源的MPs,包括内皮微粒(EMPs)、血小板微粒(PMPs)和白细胞衍生微粒(LMPs),分别通过CD144、CD41和CD45进行鉴定。结果表明,PMP水平在PCI术后即刻明显升高,并在48小时达到最高水平。此外,LMP和EMP水平在PCI术后即刻显著降低,然后随时间逐渐升高。上述三种MP类型的总量在PCI术后48小时逐渐增加。此外,冠状动脉造影Gensini评分与PMPs水平显著正相关(r2 = 0.42;P = 0.0006)。对数标准化高敏C反应蛋白也与LMPs显著相关(r2 = 0.86;P < 0.01)。总之,不同细胞来源的循环MPs变化时间进程,为STEMI中不同MPs的可能功能提供了信息。